Sodium thiosulfate appeared associated with a decreased risk for ototoxic effects when administered during platinum-based chemotherapy, according to results of a study published in JAMA Network Open.

This trial compared cisplatin with cisplatin plus delayed administration of sodium thiosulfate, aiming to reduce the incidence and severity of cisplatin-related ototoxic effects without ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

In this Perspectives article, we present the case for the testing of sodium thiosulfate in controlled trials, and for the use of CUA registries to guide the treatment of this condition.

has granted Orphan Drug Exclusivity to PEDMARK ® (sodium thiosulfate injection), which is indicated to reduce the risk of ototoxicity, or hearing loss, associated with cisplatin use in pediatric ...

The clinical trial evidence for anhydrous sodium thiosulfate is from 2 phase 3, open-label, randomised controlled trials comparing cisplatin-based chemotherapy plus anhydrous sodium thiosulfate with ...

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71 st Annual ...

There is a simple discount patient access scheme for anhydrous sodium thiosulfate. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can ...